EPO and neoplasm: Tumor cells produce pro-inflammatory cytokines (e.g., TNF-α, IL-1, IL-6) that cause anemia, reduce erythrocyte lifespan, and alter energy metabolism by altering iron homeostasis, inhibiting erythropoiesis and blocking EPO synthesis, and affecting EPO activity [37].